Cited by 418Tuberculosis Research and EpidemiologyImmune Response and Inflammationinterferon and immune responses

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Innate and Adaptive Interferons Suppress IL-1α and IL-1β Production by Distinct Pulmonary Myeloid Subsets during Mycobacterium tuberculosis Infection

Open access

Mayer-Barber, Katrin D., Andrade, Bruno B., Barber, Daniel L., Hieny, Sara, Feng, Carl G., Caspar, Patricia, Oland, Sandy, Gordon, Siamon, Sher, Alan·2011·Immunity

DOI 10.1016/j.immuni.2011.12.002PMC PMC3246221

Open this paper in CoChat — free account Open PDF

Abstract

Interleukin-1 (IL-1) receptor signaling is necessary for control of Mycobacterium tuberculosis (Mtb) infection, yet the role of its two ligands, IL-1α and IL-1β, and their regulation in vivo are poorly understood. Here, we showed that both IL-1α and IL-1β are critically required for host resistance and identified two multifunctional inflammatory monocyte-macrophage and DC populations that coexpressed both IL-1 species at the single-cell level in lungs of Mtb-infected mice. Moreover, we demonstrated that interferons (IFNs) played important roles in regulating IL-1 production by these cells in vivo. Type I interferons inhibited IL-1 production by both subsets whereas CD4(+) T cell-derived IFN-γ selectively suppressed monocyte-macrophages. These data provide a cellular basis for both the anti-inflammatory effects of IFNs and probacterial functions of type I IFNs during Mtb infection and reveal differential regulation of IL-1 production by distinct cell populations as an additional layer of complexity in the activity of IL-1 in vivo.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2011.12.002

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection.
Serbina, N., Salazar-Mather, T. P., Biron, C., Kuziel, W., & Pamer, E. (2003) · Immunity · doi:10.1016/s1074-7613(03)00171-7 · Cited by 1,293
Immunology of tuberculosis.
Flynn, J., & Chan, J. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 1,144
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Förster, I., Farlik, M., Decker, T., Pasquier, R. D., Romero, P. J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.006 · Cited by 924
Type I interferon: friend or foe?
Trinchieri, G. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20101664 · Cited by 838
I mmunity to T uberculosis
North, R. J., & Jung, Y. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104635 · Cited by 677
Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas
Cheong, C., de Matos, I. G., Choi, J., Dandamudi, D. B., Shrestha, E., Longhi, M. P., Jeffrey, K. L., Anthony, R. M., Kluger, C., Nchinda, G., et al. (2010) · Cell · doi:10.1016/j.cell.2010.09.039 · Cited by 640
Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β
Manca, C., Tsenova, L., Bergtold, A., Freeman, S. L., Tovey, M. G., Musser, J. M., Barry, C. E., Freedman, V. H., & Kaplan, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091096998 · Cited by 590

Flagged first, then by citations

Show all 48 references

Sorted by citations

Items 201–300 of 418

Differential Macrophage Response to Slow- and Fast-Growing Pathogenic Mycobacteria
Helguera‐Repetto, A. C., Chacón‐Salinas, R., Cerna-Cortés, J. F., Rivera-Gutiérrez, S., Ortiz-Navarrete, V. F., Estrada‐García, I., & González-y-Merchand, J. A. (2014) · BioMed Research International · doi:10.1155/2014/916521 · Cited by 35
Emerging Non-Antibiotic Options Targeting Uropathogenic Mechanisms for Recurrent Uncomplicated Urinary Tract Infection
Chen, Y.-C., Lee, W.-C., & Chuang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087055 · Cited by 36
The Impact of Established Immunoregulatory Networks on Vaccine Efficacy and the Development of Immunity to Malaria
de, M. M., Good, M. F., McCarthy, J. S., & Engwerda, C. R. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600619 · Cited by 31
Migration-induced cell shattering due to DOCK8 deficiency causes a type 2–biased helper T cell response
Schneider, C., Shen, C., Gopal, A. A., Douglas, T., Forestell, B., Kauffman, K. D., Rogers, D., Artusa, P., Zhang, Q., Jing, H., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0795-1 · Cited by 31
Self-citation
Mycobacterial PPE13 activates inflammasome by interacting with the NATCH and LRR domains of NLRP3
Yang, Y., Xu, P., He, P., Shi, F., Tang, Y., Guan, C., Zeng, H., Zhou, Y., Song, Q., Zhou, B., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000200rr · Cited by 33
Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in Disease
Fox, L. E., Locke, M. C., & Lenschow, D. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.606874 · Cited by 36
Down regulation of macrophage IFNGR1 exacerbates systemic L. monocytogenes infection
Eshleman, E. M., Delgado, C., Kearney, S. J., Friedman, R. S., & Lenz, L. L. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006388 · Cited by 30
Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4 + T-Cell Responses for Vaccine Control of Tuberculosis
Orr, M. T., Windish, H. P., Beebe, E. A., Argilla, D., Huang, P.-W. D., Reese, V. A., Reed, S. G., & Coler, R. N. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv055 · Cited by 31
The Functional Response of B Cells to Antigenic Stimulation: A Preliminary Report of Latent Tuberculosis
du Plessis, W. J., Kleynhans, L., du Plessis, N., Stanley, K., Malherbe, S. T., Maasdorp, E., Ronacher, K., Chegou, N. N., Walzl, G., & Loxton, A. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152710 · Cited by 33
Role of Pattern Recognition Receptor in Sensing Mycobacterium Tuberculosis
Zihad, S. M. N. K., Sifat, N., Islam, M. A., Monjur-Al-Hossain, A. S. M., Sikdar, K. Y. K., Sarker, M. M. R., Shilpi, J. A., & Uddin, S. J. (2022) · Heliyon · doi:10.1016/j.heliyon.2023.e20636 · Cited by 37
Molecular degree of perturbation of plasma inflammatory markers associated with tuberculosis reveals distinct disease profiles between Indian and Chinese populations
Oliveira-de-Souza, D., Vinhaes, C. L., Arriaga, M. B., Kumar, N. P., Cubillos-Angulo, J. M., Shi, R., Wei, W., Yuan, X., Zhang, G., Cai, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44513-8 · Cited by 30
Self-citation
The Roles of Inflammasomes in Host Defense against Mycobacterium tuberculosis
Ma, J., Zhao, S., Gao, X., Wang, R., Liu, J., Zhou, X., & Zhou, Y. (2021) · Pathogens · doi:10.3390/pathogens10020120 · Cited by 29
Assessing vaccine-mediated protection in an ultra-low dose Mycobacterium tuberculosis murine model
Plumlee, C. R., Barrett, H. W., Shao, D., Lien, K. A., Cross, L. M., Cohen, S. B., Edlefsen, P. T., & Urdahl, K. B. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011825 · Cited by 28
Tuberculosis antigen‐induced expression of IFN‐α in tuberculosis patients inhibits production of IL‐1β
Ma, J., Yang, B., Yu, S., Zhang, Y., Zhang, X., Lao, S., Chen, X., Li, B., & Wu, C. Y. (2014) · The FASEB Journal · doi:10.1096/fj.13-247056 · Cited by 31
Duality of lipid mediators in host response against Mycobacterium tuberculosis: good cop, bad cop
Dietzold, J., Gopalakrishnan, A., & Salgame, P. (2015) · F1000Prime Reports · doi:10.12703/p7-29 · Cited by 27
Dimethyl itaconate is effective in host-directed antimicrobial responses against mycobacterial infections through multifaceted innate immune pathways
Kim, Y. J., Park, E. J., Lee, S.-H., Silwal, P., Kim, J. K., Yang, J. S., Whang, J., Jang, J., Kim, J., & Jo, E. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00992-x · Cited by 28
Tolerating the Unwelcome Guest; How the Host Withstands Persistent Mycobacterium tuberculosis
Olive, A. J., & Sassetti, C. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02094 · Cited by 27
Mycobacterium tuberculosis MmsA (Rv0753c) Interacts with STING and Blunts the Type I Interferon Response
Sun, Y., Zhang, W., Dong, C., & Xiong, S. (2020) · mBio · doi:10.1128/mbio.03254-19 · Cited by 29
Mycobacterium tuberculosis exploits MPT64 to generate myeloid-derived suppressor cells to evade the immune system
Singh, S., Maurya, S. K., Aqdas, M., Bashir, H., Arora, A., Bhalla, V., & Agrewala, J. N. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04596-5 · Cited by 28
Immunotherapy Added to Antibiotic Treatment Reduces Relapse of Disease in a Mouse Model of Tuberculosis
Mourik, B. C., Leenen, P. J. M., de Knegt, G. J., Huizinga, R., van der Eerden, B. C. J., Wang, J., Krois, C. R., Napoli, J. L., Bakker‐Woudenberg, I. A. J. M., & de Steenwinkel, J. E. M. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0185oc · Cited by 27
Mycobacterium tuberculosis clinical isolates of the Beijing and East-African Indian lineage induce fundamentally different host responses in mice compared to H37Rv
Mourik, B. C., de Steenwinkel, J. E. M., de Knegt, G. J., Huizinga, R., Verbon, A., Ottenhoff, T. H. M., van Soolingen, D., & Leenen, P. J. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-56300-6 · Cited by 27
How mycobacteria take advantage of the weakness in human immune system in the modern world
Chao, W.-C., Yen, C., Wu, C., & Shieh, C.-C. K. (2019) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2019.10.008 · Cited by 25
Effect of Inflammatory Cytokines/Chemokines on Pulmonary Tuberculosis Culture Conversion and Disease Severity in HIV-Infected and -Uninfected Individuals From South Africa
Rambaran, S., Naidoo, K., Lewis, L., Hassan-Moosa, R., Govender, D., Samsunder, N., Scriba, T. J., Padayatchi, N., & Sivro, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.641065 · Cited by 26
Pathogenicity of Type I Interferons in Mycobacterium tuberculosis
Mundra, A., Yegiazaryan, A., Karsian, M., Alsaigh, D., Bonavida, V., Frame, M., May, N., Gargaloyan, A., Abnousian, A., & Venketaraman, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043919 · Cited by 28
Reverse Translation in Tuberculosis: Neutrophils Provide Clues for Understanding Development of Active Disease
Dorhoi, A., Iannaccone, M., Maertzdorf, J., Nouailles, G., Weiner, J. M., & Kaufmann, S. H. E. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00036 · Cited by 27
The Immune Interaction between HIV-1 Infection andMycobacterium tuberculosis
Bruyn, E. D., & Wilkinson, R. J. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0012-2016 · Cited by 28
Type I Interferons Are Involved in the Intracellular Growth Control of Mycobacterium abscessus by Mediating NOD2-Induced Production of Nitric Oxide in Macrophages
Ahn, J., Park, J., Kim, D., Lee, T., Jung, D., Kim, Y.-J., Lee, Y., Lee, Y., Seo, I.-S., Song, E., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.738070 · Cited by 24
PE17 protein from Mycobacterium tuberculosis enhances Mycobacterium smegmatis survival in macrophages and pathogenicity in mice
Li, Z., Liu, H., Li, H., Dang, G., Cui, Z., Song, N., Wang, Q., Liu, S., & Chen, L. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.10.030 · Cited by 25
Type I IFN drives neutrophil swarming, impeding lung T cell–macrophage interactions and TB control
Branchett, W. J., Stavropoulos, E., Shields, J. M., Al‐Dibouni, A., Cardoso, M. S., Fernandes, A. I., Moreira-Teixeira, L., Slawinski, H., Mikolajczak, A., Rodgers, A., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20250466 · Cited by 28
Histone deacetylase-2 controls IL-1β production through the regulation of NLRP3 expression and activation in tuberculosis infection
Moreira, J. D., Iakhiaev, A. V., Vankayalapati, R., Jung, B., & Samten, B. (2022) · iScience · doi:10.1016/j.isci.2022.104799 · Cited by 24
Allergen‐specific immunotherapy induces monocyte‐derived dendritic cells but attenuates their maturation and cytokine production in the lesional skin of an atopic dermatitis mouse model
Feng, S., Song, G., Liu, L., Liu, W., Liang, G., & Song, Z. (2022) · The Journal of Dermatology · doi:10.1111/1346-8138.16582 · Cited by 25
MyD88 signalling in myeloid cells is sufficient to prevent chronic mycobacterial infection
Berod, L., Stüve, P., Swallow, M., Arnold‐Schrauf, C., Kruse, F., Gentilini, M. V., Freitag, J., Holzmann, B., & Sparwasser, T. D. (2014) · European Journal of Immunology · doi:10.1002/eji.201344039 · Cited by 24
Potential and development of inhaled RNAi therapeutics for the treatment of pulmonary tuberculosis
Man, D. K.-W., Chow, M. Y. T., Casettari, L., Juarrero, M. G., & Lam, J. K. W. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.013 · Cited by 26
Autophagy Impairment Is Associated With Increased Inflammasome Activation and Reversal Reaction Development in Multibacillary Leprosy
Barbosa, M. G. D. M., Silva, B. J. D. A., Assis, T. Q., Prata, R. B. D. S., Ferreira, H., Andrade, P. R., de Oliveira, J. A. D. P., da Silva, G. M. S., Nery, J. A. D. C., Sarno, E. N., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01223 · Cited by 24
Co-infection of mice with SARS-CoV-2 and Mycobacterium tuberculosis limits early viral replication but does not affect mycobacterial loads
Baker, P. J., Amaral, E. P., Castro, E., Bohrer, A. C., Torres-Juárez, F., Jordan, C. M., Nelson, C. E., Barber, D. L., Johnson, R. F., Hilligan, K. L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1240419 · Cited by 20
Self-citation
Tuberculosis as an unconventional interferonopathy
Vance, R. E. (2024) · Current Opinion in Immunology · doi:10.1016/j.coi.2024.102508 · Cited by 24
AIM2 inhibits autophagy and IFN-β production during M. bovis infection
Liu, C., Yue, R., Yang, Y., Cui, Y., Yang, L., Zhao, D., & Zhou, X. (2016) · Oncotarget · doi:10.18632/oncotarget.10503 · Cited by 22
The Troika Host–Pathogen–Extrinsic Factors in Tuberculosis: Modulating Inflammation and Clinical Outcomes
Bastos, H. N., Osório, N. S., Gagneux, S., Comas, I., & Saraiva, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01948 · Cited by 23
Molecular Markers of Early Immune Response in Tuberculosis: Prospects of Application in Predictive Medicine
Diatlova, A., Linkova, N. S., Lavrova, A. I., Zinchenko, Y. S., Медведев, Д. С., Krasichkov, A. S., Polyakova, V. O., & Yаblonskiy, P. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713261 · Cited by 23
The role of STAT-6 as a key transcription regulator in HeLa cell death induced by IFN-γ/TNF-α co-immobilized on nanoparticles
Li, Z., Guan, Y., & Liu, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.004 · Cited by 22
Tuberculosis: Smart manipulation of a lethal host
Chaurasiya, S. K. (2018) · Microbiology and Immunology · doi:10.1111/1348-0421.12593 · Cited by 25
Comparative study of interruption of signaling pathways in lung epithelial cell by two different Mycobacterium tuberculosis lineages
Hadifar, S., Behrouzi, A., Fateh, A., Khatami, S., Jamnani, F. R., Siadat, S. D., & Vaziri, F. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27271 · Cited by 22
Cytomegalovirus antibody responses associated with increased risk of TB disease in Ugandan adults
Stockdale, L. K., Nash, S., Farmer, R. E., Raynes, J. G., Mallikaarjun, S., Newton, R., & Fletcher, H. A. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz581 · Cited by 22
Role of Tumor Necrosis Factor in Tuberculosis
Дмитриевич, К. Ф., Lopatnikova, J., Alshevskaya, A., & Sennikov, S. V. (2025) · Biomolecules · doi:10.3390/biom15050709 · Cited by 28
Inhibition of type I interferon signaling abrogates early Mycobacterium bovis infection
Wang, J., Hussain, T. A., Zhang, K., Liao, Y., Yao, J., Song, Y., Sabir, N., Cheng, G., Dong, H., Li, M., et al. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4654-3 · Cited by 21
DNA methyltransferase inhibition promotes recruitment of myeloid-derived suppressor cells to the tumor microenvironment through induction of tumor cell-intrinsic interleukin-1
Traynor, S., Terp, M. G., Nielsen, A., Guldberg, P., Jakobsen, M. K., Pedersen, P. G., Gammelgaard, O. L., Pedersen, C. B., Pedersen, M., Rattenborg, S., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215982 · Cited by 22
Mycobacterium tuberculosis infection triggers epigenetic changes that are enriched in a type I IFN signature
Madden, K., Hamra, R. E., Berton, S., Felker, J., Alvarez, G. G., Blais, A., & Sun, J. (2023) · microLife · doi:10.1093/femsml/uqad006 · Cited by 26
Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating type I IFN production
Thirunavukkarasu, S., Ahmed, M., Rosa, B. A., Boothby, M. R., Cho, S. H., Rangel‐Moreno, J., Mbandi, S. K., Schreiber, V., Gupta, A., Zúñiga, J., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci158630 · Cited by 23
Gene Expression Profile of Human Cytokines in Response to Burkholderia pseudomallei Infection
Krishnananthasivam, S., Sathkumara, H. D., Corea, E. M., Natesan, M., & Silva, A. D. D. (2017) · mSphere · doi:10.1128/msphere.00121-17 · Cited by 20
Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses
Llibre, A., Smith, N., Rouilly, V., Musvosvi, M., Nemes, E., Posseme, C., Mabwe, S., Charbit, B., Mbandi, S. K., Filander, E., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.897193 · Cited by 19
IFN-β: A Contentious Player in Host–Pathogen Interaction in Tuberculosis
Sabir, N., Hussain, T. A., Shah, S. Z. A., Zhao, D., & Zhou, X. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122725 · Cited by 21
Infection resisters: targets of new research for uncovering natural protective immunity against Mycobacterium tuberculosis
Kaipilyawar, V., & Salgame, P. R. (2019) · F1000Research · doi:10.12688/f1000research.19805.1 · Cited by 19
Altered IFN-γ–Mediated Immunity and Transcriptional Expression Patterns in N-Ethyl-N-Nitrosourea–Induced STAT4 Mutants Confer Susceptibility to Acute Typhoid-like Disease
Eva, M. M., Yuki, K. E., Dauphinee, S. M., Schwartzentruber, J., Pyzik, M., Paquet, M., Lathrop, M. G., Majewski, J., Vidal, S. M., & Malo, D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301370 · Cited by 17
Granulocytes subsets and their divergent functions in host resistance to Mycobacterium tuberculosis — a ‘tipping-point’ model of disease exacerbation
Mayer-Barber, K. D. (2023) · Current Opinion in Immunology · doi:10.1016/j.coi.2023.102365 · Cited by 18
Self-citation
Gamma Interferon and Interleukin-17A Differentially Influence the Response of Human Macrophages and Neutrophils to Pseudomonas aeruginosa Infection
Muntaka, S., Almuhanna, Y., Jackson, D., Singh, S., Afryie-Asante, A., Cámara, M., & Martínez‐Pomares, L. (2018) · Infection and Immunity · doi:10.1128/iai.00814-18 · Cited by 18
Immunology ofMycobacterium tuberculosisInfections
Sia, J. K., & Rengarajan, J. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch64 · Cited by 22
The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication
Baker, P. J., Bohrer, A. C., Castro, E., Amaral, E. P., Snow-Smith, M., Torres-Juárez, F., Gould, S. T., Queiroz, A. T. L., Fukutani, E. R., Jordan, C. M., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adp7951 · Cited by 17
Self-citation
Single-cell analysis reveals Mycobacterium tuberculosis ESX-1–mediated accumulation of permissive macrophages in infected mouse lungs
Zheng, W., Borja, M., Dorman, L. C., Liu, J., Zhou, A., Seng, A., Arjyal, R., Sunshine, S., Nalyvayko, A., Pisco, A. O., et al. (2025) · Science Advances · doi:10.1126/sciadv.adq8158 · Cited by 19
IL-1R1-positive dorsal raphe neurons drive self-imposed social withdrawal in sickness
Yang, L., Andina, M., Witkowski, M., King, H. O., Wickersham, I. R., Huh, J. R., & Choi, G. B. (2025) · Cell · doi:10.1016/j.cell.2025.10.040 · Cited by 21
Lipopolysaccharide-induced interferon response networks at birth are predictive of severe viral lower respiratory infections in the first year of life
Read, J. F., Serralha, M., Mok, D., Holt, B. J., Cruickshank, M. N., Karpievitch, Y. V., Broadhurst, D., Sly, P. D., Strickland, D. H., Reinke, S. N., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.876654 · Cited by 17
Inflammasome Activation Dampens Type I IFN Signaling to Strengthen Anti- Toxoplasma Immunity
Hu, Z., Wu, D., Lu, J., Zhang, Y., Yu, S.-M., Xie, Y., Li, H., Yang, J., Lai, D., Zeng, K., et al. (2022) · mBio · doi:10.1128/mbio.02361-22 · Cited by 19
Interleukin-1 and Interferon-γ Orchestrate β-Glucan-Activated Human Dendritic Cell Programming via IκB-ζ Modulation
Cardone, M., Dzutsev, A., Li, H., Riteau, N., Gerosa, F., Shenderov, K., Winkler-Pickett, R. T., Provezza, L., Riboldi, E., Leighty, R. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114516 · Cited by 17
Self-citation
The RD1 locus in theMycobacterium tuberculosisgenome contributes to the maturation and secretion of IL-1α from infected macrophages through the elevation of cytoplasmic calcium levels and calpain activation
Yang, R., Chen, X., Dewamitta, S. R., Sakai, S., Tsuchiya, K., Hara, H., Shen, Y., Qu, H., Fang, R., Mitsuyama, M., et al. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12075 · Cited by 17
Reduced systemic and mycobacterial antigen-stimulated concentrations of IL-1β and IL-18 in tuberculous lymphadenitis
Kathamuthu, G. R., Moideen, K., Bhaskaran, D., Sekar, G., Sridhar, R., Vidyajayanthi, B., Gajendraraj, G., & Babu, S. (2016) · Cytokine · doi:10.1016/j.cyto.2016.10.013 · Cited by 17
NLRP3 inflammasome is attenuated in patients with Mycobacterium avium complex lung disease and correlated with decreased interleukin-1β response and host susceptibility
Wu, M., Shu, C., Wang, J., Yan, B., Lai, H., Chiang, B., Wu, L. S., & Yu, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-47609-3 · Cited by 18
Therapeutic Administration of a Monoclonal Anti-Il-1β Antibody Protects Against Experimental Melioidosis
Weehuizen, T. A. F., Lankelma, J. M., de Jong, H. K., de Boer, O. J., Roelofs, J. J. T. H., Day, N., Gram, H., de Vos, A. F., & Wiersinga, W. J. (2016) · Shock · doi:10.1097/shk.0000000000000625 · Cited by 17
Human Alveolar and Splenic Macrophage Populations Display a Distinct Transcriptomic Response to Infection With Mycobacterium tuberculosis
Lavalett, L., Ortega, H., & Barrera, L. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00630 · Cited by 20
Vaccinia Virus Infection Inhibits Skin Dendritic Cell Migration to the Draining Lymph Node
Aggio, J. B., Krmeská, V., Ferguson, B. J., Wowk, P. F., & Rothfuchs, A. G. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000928 · Cited by 16
Impact of diabetes mellitus on immunity to latent tuberculosis infection
Kumar, N. P., & Babu, S. (2023) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2023.1095467 · Cited by 22
Human Alveolar and Monocyte-Derived Human Macrophage Responses to Mycobacterium tuberculosis
Campo, M., Dill‐McFarland, K. A., Peterson, G. J., Benson, B., Skerrett, S. J., & Hawn, T. R. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300885 · Cited by 15
Shaping the niche in macrophages: Genetic diversity of the M. tuberculosis complex and its consequences for the infected host
Reiling, N., Homolka, S., Kohl, T. A., Steinhäuser, C., Kolbe, K., Schütze, S., & Brandenburg, J. (2017) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2017.09.009 · Cited by 15
Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection
Schleicher, U., Liese, J., Justies, N., Mischke, T., Haeberlein, S., Sebald, H., Kalinke, U., Weiß, S., & Bogdan, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00079 · Cited by 15
The Mycobacterium tuberculosis PhoPR virulence system regulates expression of the universal second messenger c-di-AMP and impacts vaccine safety and efficacy
Pérez, I., Campos‐Pardos, E., Díaz, C., Uranga, S., Sayes, F., Vicente, F., Aguiló, N., Brosch, R., Martı́n, C., & Gonzalo‐Asensio, J. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.02.011 · Cited by 17
Is Receptor-Interacting Protein Kinase 3 a Viable Therapeutic Target for Mycobacterium tuberculosis Infection?
Stutz, M. D., Ojaimi, S., Ebert, G., & Pellegrini, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01178 · Cited by 16
Polymorphisms in interferon pathway genes and risk of Mycobacterium tuberculosis infection in contacts of tuberculosis cases in Brazil
Cubillos-Angulo, J. M., Arriaga, M. B., de Melo, M. G. M., Silva, E., Alvarado-Arnez, L. E., de Almeida, A. S., Moraes, M. O., Moreira, A. S. R., Silva, J. R. L. E., Fukutani, K. F., et al. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.12.013 · Cited by 16
Self-citation
Extracellular mycobacterial DNA drives disease progression by triggering Caspase-11-dependent pyroptosis of infected macrophagesPreprint
Varela, M., van der Vaart, M., Groenewoud, A., & Meijer, A. H. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/514125 · Cited by 16
Role of Type I Interferons during Mycobacterium tuberculosis and HIV Infections
Anes, E., Azevedo‐Pereira, J. M., & Pires, D. (2024) · Biomolecules · doi:10.3390/biom14070848 · Cited by 15
Innate type 1 immune response, but not IL-17 cells control tuberculosis infection
Segueni, N., Jacobs, M., & Ryffel, B. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.06.011 · Cited by 18
Immune and repair responses in joint tissues and lymph nodes after knee arthroplasty surgery in mice
Xia, Y., Sokhi, U. K., Bell, R. D., Pannellini, T., Turajane, K., Niu, Y., Frye, L., Chao, M., Ayturk, U. M., Otero, M., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4381 · Cited by 15
Systems Approach to Understand the Immune Response in Tuberculosis: An Iterative Process between Mouse Models and Human DiseasePreprint
O’Garra, A. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020172 · Cited by 15
Mycobacterial-specific secretion of cytokines and chemokines in healthcare workers with apparent resistance to infection with Mycobacterium tuberculosis
Shey, M. S., Balfour, A., Masina, N., Bekiswa, A., Schutz, C., Goliath, R. T., Dielle, R., Katoto, P. D., Wilkinson, K. A., Lewinsohn, D. M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1176615 · Cited by 14
Aging increases the systemic molecular degree of inflammatory perturbation in patients with tuberculosis
Oliveira-de-Souza, D., Vinhaes, C. L., Arriaga, M. B., Kumar, N. P., Queiroz, A. T. L., Fukutani, K. F., Babu, S., & Andrade, B. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-68255-0 · Cited by 15
Self-citation
The recent trend in mycobacterial strain diversity among extra pulmonary lymph node tuberculosis and their association with drug resistance and the host immunological response in South India
Sivakumar, S., Chandramohan, Y., Kathamuthu, G. R., Sekar, G., Kandhasamy, D., Padmanaban, V., Hissar, S. S., Tripathy, S. P., Bethunaickan, R., Baskaran, D., et al. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05597-0 · Cited by 14
Striking the right immunological balance prevents progression of tuberculosis
Vyas, S., & Goswami, R. (2017) · Inflammation Research · doi:10.1007/s00011-017-1081-z · Cited by 17
Alcohol enhances type 1 interferon-α production and mortality in young mice infected with Mycobacterium tuberculosis
Tripathi, D., Welch, E., Cheekatla, S. S., Radhakrishnan, R. K., Venkatasubramanian, S., Paidipally, P., Van, A., Samten, B., Devalraju, K. P., Neela, V. S. K., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007174 · Cited by 15
Cell surface IL‐1α trafficking is specifically inhibited by interferon‐γ, and associates with the membrane via IL‐1R2 and GPI anchors
Chan, J. N. E., Humphry, M., Kitt, L., Krzyzanska, D., Filbey, K. J., Bennett, M. R., & Clarke, M. C. H. (2020) · European Journal of Immunology · doi:10.1002/eji.201948521 · Cited by 15
Cytokines and Chemokines inMycobacterium tuberculosisInfection
Domingo-Gonzalez, R., Prince, O. A., Cooper, A. M., & Khader, S. A. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch2 · Cited by 15
Deconvoluting the interplay of innate and adaptive immunity in BCG-induced nonspecific and TB-specific host resistance
Hilligan, K. L., Darrah, P. A., Seder, R. A., & Sher, A. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20240496 · Cited by 13
Self-citation
The role of inflammasomes as central inflammatory hubs in Mycobacterium tuberculosis infection
Theobald, S. J., Müller, T. A., Lange, D., Keck, K., & Rybniker, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1436676 · Cited by 13
Breaking self-tolerance during autoimmunity and cancer immunity: Myeloid cells and type I IFN response regulation
Tarbell, K. V., & Egen, J. G. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir1017-400r · Cited by 15
Mitochondrial Transcription Factor A Regulates Mycobacterium bovis–Induced IFN-β Production by Modulating Mitochondrial DNA Replication in Macrophages
Song, Y., Hussain, T. A., Wang, J., Liao, Y., Yue, R., Sabir, N., Zhao, D., & Zhou, X. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz461 · Cited by 13
Tacrolimus interacts with voriconazole to reduce the severity of fungal keratitis by suppressing IFN-related inflammatory responses and concomitant FK506 and voriconazole treatment suppresses fungal keratitis.
Zhong, J., Peng, L., Wang, B., Zhang, H., Li, S., Yang, R., Deng, Y., Huang, H., & Yuan, J. (2018) · PubMed Central · Cited by 13
Mycobacterium tuberculosis Utilizes Serine/Threonine Kinase PknF to Evade NLRP3 Inflammasome-driven Caspase-1 and RIPK3/Caspase-8 Activation in Murine Dendritic Cells
Rastogi, S., Ganesh, A., & Briken, V. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300753 · Cited by 11
Transcriptional analysis of human peripheral blood mononuclear cells stimulated by Mycobacterium tuberculosis antigen
Wei, J., Guo, F., Song, Y., Xu, K., Lin, F., Li, K., Li, B., Qian, Z., Wang, X., Wang, H., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1255905 · Cited by 15
Akkermansia muciniphila induces slow extramedullary hematopoiesis via cooperative IL‐1R/TLR signals
Wang, Y., Morishima, T., Sezaki, M., Sato, R., Nakato, G., Fukuda, S., Kobiyama, K., Ishii, K. J., Li, Y., & Takizawa, H. (2023) · EMBO Reports · doi:10.15252/embr.202357485 · Cited by 14
Pulmonary tuberculosis epidemiology and genetics in Kazakhstan
Yerezhepov, D., Gabdulkayum, A., Akhmetova, A., Kozhamkulov, U. A., Rakhimova, S., Kairov, U., Zhunussova, G., Kalendar, R. N., & Akilzhanova, A. R. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1340673 · Cited by 11
Unmasking the hidden impact of viruses on tuberculosis risk
Darboe, F., Reijneveld, J. F., Maison, D. P., Martínez, L., & Suliman, S. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.07.008 · Cited by 11
Deviant Behavior: Tick-Borne Pathogens and Inflammasome Signaling
Shaw, D. K., McClure, E. E., Wang, X., & Pedra, J. H. F. (2016) · Veterinary Sciences · doi:10.3390/vetsci3040027 · Cited by 12
Tuberculosis
Hopewell, P. C., Kato‐Maeda, M., & Ernst, J. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00035-x · Cited by 11
Deficiency of the Intramembrane Protease SPPL2a Alters Antimycobacterial Cytokine Responses of Dendritic Cells
Gradtke, A.-C., Mentrup, T., Lehmann, C. H. K., Cabrera-Cabrera, F., Desel, C., Okakpu, D., Assmann, M., Dalpke, A. H., Schaible, U. E., Dudziak, D., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000151 · Cited by 11

Authors: Mayer-Barber, K. D., Andrade, B. B., Barber, D. L., Hieny, S., Feng, C. G., Caspar, P., Oland, S., Gordon, S., & Sher, A.
Affiliations: National Institutes of Health (US)
University of Oxford (GB)
Corresponding author: Mayer-Barber, Katrin D.
Sher, Alan
ORCID: Mayer-Barber, Katrin D.
Andrade, Bruno B.
Barber, Daniel L.
Feng, Carl G.
Gordon, Siamon
Sher, Alan
Venue: Immunity
Publisher: Elsevier BV
Published: 2011-12
Volume: 35
Issue: 6
Pages: 1023-1034
ISSN: 1074-7613 (ISSN-L)
DOI: 10.1016/j.immuni.2011.12.002
PMC: PMC3246221
OpenAlex: W2023478821
Cited by: 418
References: 48
Citations by year: 2026: 16 · 2025: 26 · 2024: 25 · 2023: 31 · 2022: 33 · 2021: 18 · 2020: 27 · 2019: 31 · 2018: 23 · 2017: 31 · 2016: 38 · 2015: 37 · 2014: 31 · 2013: 37 · 2012: 14
FWCI: 17.77
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 594 d)
Locations: Immunity (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (Z99 AI999999)
National Cancer Institute
National Institute of Allergy and Infectious Diseases (Y99 AI999999)
Topics: Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Keywords: Mycobacterium tuberculosis infection, interleukin-1 alpha, IL-1β, type I interferon, innate immunity, adaptive immunity, monocytes/macrophages, dendritic cells, host resistance, IL-1 signaling, single-cell analysis
MeSH terms: Animals, Antigens, Ly, Dendritic Cells, Humans, Interferons, Lung, Mice, Inbred C57BL, Mycobacterium tuberculosis, Phagocytes, Tuberculosis, Pulmonary, Signal Transduction, CD4-Positive T-Lymphocytes, Mice, Knockout, Myeloid Cells, CD11b Antigen, Mice, Interleukin-1alpha, Interleukin-1beta, Interleukin-12 Subunit p40

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Innate and Adaptive Interferons Suppress IL-1α and IL-1β Production by Distinct Pulmonary Myeloid Subsets during Mycobacterium tuberculosis Infection

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks